| Quality of private and public ambulatory health care in low and middle income countries: systematic review of comparative studies S Berendes, P Heywood, S Oliver, P Garner PLoS medicine 8 (4), e1000433, 2011 | 435 | 2011 |
| Addressing the slow uptake of HIV testing in Malawi: the role of stigma, self-efficacy, and knowledge in the Malawi BRIDGE Project S Berendes, RN Rimal Journal of the Association of Nurses in AIDS Care 22 (3), 215-228, 2011 | 94 | 2011 |
| Inflammation and change in body weight with antiretroviral therapy initiation in a multinational cohort of HIV-infected adults V Mave, KM Erlandson, N Gupte, A Balagopal, DM Asmuth, TB Campbell, ... The Journal of infectious diseases 214 (1), 65-72, 2016 | 68 | 2016 |
| Sex-related differences in inflammatory and immune activation markers before and after combined antiretroviral therapy initiation JS Mathad, N Gupte, A Balagopal, D Asmuth, J Hakim, B Santos, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 73 (2), 123-129, 2016 | 60 | 2016 |
| New evidence on the HIV epidemic in Libya: why countries must implement prevention programs among people who inject drugs L Mirzoyan, S Berendes, C Jeffery, J Thomson, HB Othman, L Danon, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (5), 577-583, 2013 | 54 | 2013 |
| Are patent medicine vendors effective agents in malaria control? Using lot quality assurance sampling to assess quality of practice in Jigawa, Nigeria S Berendes, O Adeyemi, EA Oladele, OB Oresanya, F Okoh, JJ Valadez Public Library of Science 7 (9), e44775, 2012 | 50 | 2012 |
| Vitamin A and D deficiencies associated with incident tuberculosis in HIV-infected patients initiating antiretroviral therapy in multinational case-cohort study MW Tenforde, A Yadav, DW Dowdy, N Gupte, R Shivakoti, WT Yang, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 75 (3), e71-e79, 2017 | 48 | 2017 |
| Filling the knowledge gap: measuring HIV prevalence and risk factors among men who have sex with men and female sex workers in Tripoli, Libya JJ Valadez, S Berendes, C Jeffery, J Thomson, H Ben Othman, L Danon, ... PLoS One 8 (6), e66701, 2013 | 45 | 2013 |
| Prevalence and risk factors of micronutrient deficiencies pre-and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults R Shivakoti, P Christian, WT Yang, N Gupte, N Mwelase, C Kanyama, ... Clinical nutrition 35 (1), 183-189, 2016 | 42 | 2016 |
| Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings FP Havers, B Detrick, SW Cardoso, S Berendes, JR Lama, ... PloS one 9 (4), e95164, 2014 | 41 | 2014 |
| Assessing the quality of care in a new nation: South Sudan's first national health facility assessment S Berendes, RL Lako, D Whitson, S Gould, JJ Valadez Tropical Medicine & International Health 19 (10), 1237-1248, 2014 | 34 | 2014 |
| Concurrent anemia and elevated C-reactive protein predicts HIV clinical treatment failure, including tuberculosis, after antiretroviral therapy initiation R Shivakoti, WT Yang, N Gupte, S Berendes, AL Rosa, SW Cardoso, ... Clinical Infectious Diseases 61 (1), 102-110, 2015 | 29 | 2015 |
| Diagnostic infectious diseases testing outside clinics: a global systematic review and meta-analysis EE Kpokiri, G Marley, W Tang, N Fongwen, D Wu, S Berendes, B Ambil, ... Open forum infectious diseases 7 (10), ofaa360, 2020 | 28 | 2020 |
| Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy SA Fiscus, S Cu-Uvin, AT Eshete, MD Hughes, Y Bao, M Hosseinipour, ... Clinical infectious diseases 57 (2), 290-297, 2013 | 26 | 2013 |
| Persistently elevated C-reactive protein level in the first year of antiretroviral therapy, despite virologic suppression, is associated with HIV disease progression in … R Shivakoti, WT Yang, S Berendes, N Mwelase, C Kanyama, S Pillay, ... The Journal of infectious diseases 213 (7), 1074-1078, 2016 | 23 | 2016 |
| Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy R Shivakoti, N Gupte, WT Yang, N Mwelase, C Kanyama, AM Tang, ... Nutrients 6 (11), 5061-5078, 2014 | 22 | 2014 |
| Sexual health interventions delivered to participants by mobile technology: a systematic review and meta-analysis of randomised controlled trials S Berendes, A Gubijev, OL McCarthy, MJ Palmer, E Wilson, C Free Sexually Transmitted Infections 97 (3), 190-200, 2021 | 19 | 2021 |
| Continued elevation of interleukin-18 and interferon-γ after initiation of antiretroviral therapy and clinical failure in a diverse multicountry human immunodeficiency virus cohort A Balagopal, N Gupte, R Shivakoti, AL Cox, WT Yang, S Berendes, ... Open Forum Infectious Diseases 3 (3), ofw118, 2016 | 19 | 2016 |
| PEARLS (ACTG A5175): a multinational study of didanosine-EC, emtricitabine and atazanavir vs. co-formulated zidovudine/lamivudine and efavirenz for initial treatment of HIV-1 … T Campbell, L Smeaton, V De Grutolla, J Hakim, N Kumarasamy, ... XVII International AIDS Conference, 3-8, 2008 | 19 | 2008 |
| New Work Concept Sheet 319 and AIDS Clinical Trials Group A5175 (PEARLS) Study Teams. Sex-related differences in inflammatory and immune activation markers before and after … JS Mathad, N Gupte, A Balagopal, D Asmuth, J Hakim, B Santos, ... J Acquir Immune Defic Syndr 73 (2), 123-129, 2016 | 15 | 2016 |
